GoHealth (GOCO)
(Delayed Data from NSDQ)
$10.15 USD
+0.14 (1.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.15 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$10.15 USD
+0.14 (1.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.15 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value B Growth B Momentum C VGM
Zacks News
Cboe Global (CBOE) to Introduce New Options on Bond Index
by Zacks Equity Research
Cboe Global (CBOE) intends to launch new options on Cboe iBoxx iShares Bond Index futures to aid investors mitigate risk in corporate bond portfolios.
Here's Why Should You Stay Invested in Nasdaq (NDAQ) Stock
by Zacks Equity Research
Improving organic growth, focus on ramping up the on-trading revenue base, buyouts to capitalize on growing market opportunities, effective capital deployment poise Nasdaq (NDAQ) for growth.
GoHealth (GOCO) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
GoHealth (GOCO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Manulife's (MFC) Hong Kong Unit Expands China Hospital Network
by Zacks Equity Research
Manulife's (MFC) Manulife Hong Kong expanded its Designated China Hospital Network from 1,700 to more than 3,000 listed hospitals across Mainland China.
Manulife Financial (MFC) Up 8% YTD: Will the Rally Continue?
by Zacks Equity Research
A growing Asia business, expanding Wealth and Asset Management business, cost savings to improve profitability and solid capital position poise Manulife (MFC) well for growth.
GoHealth (GOCO) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
GoHealth (GOCO) delivered earnings and revenue surprises of 35.63% and 1.21%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
First Business Financial Services (FBIZ) Q1 Earnings Lag Estimates
by Zacks Equity Research
First Business Financial Services (FBIZ) delivered earnings and revenue surprises of -6.25% and 4.04%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in GoHealth (GOCO) Stock?
by Zacks Equity Research
Investors need to pay close attention to GoHealth (GOCO) stock based on the movements in the options market lately.
Here Is Why Bargain Hunters Would Love Fast-paced Mover GoHealth (GOCO)
by Zacks Equity Research
GoHealth (GOCO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Is GoHealth (GOCO) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
All You Need to Know About GoHealth (GOCO) Rating Upgrade to Buy
by Zacks Equity Research
GoHealth (GOCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Are Options Traders Betting on a Big Move in GoHealth (GOCO) Stock?
by Zacks Equity Research
Investors need to pay close attention to GoHealth (GOCO) stock based on the movements in the options market lately.
GoHealth (GOCO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
GoHealth (GOCO) delivered earnings and revenue surprises of -4.55% and 9.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Primerica (PRI) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Primerica (PRI) delivered earnings and revenue surprises of 0.67% and 0.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
American Equity Investment (AEL) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
American Equity (AEL) delivered earnings and revenue surprises of 17.86% and 4.22%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GoHealth (GOCO) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
GoHealth (GOCO) delivered earnings and revenue surprises of 21.05% and 23.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
New York City REIT, Inc. (NYC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
New York City REIT, Inc. (NYC) delivered FFO and revenue surprises of -83.33% and 1.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Kingstone Companies, Inc (KINS) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Kingstone Companies, Inc (KINS) delivered earnings and revenue surprises of -221.43% and 6.99%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Manulife Financial (MFC) Q2 Earnings Beat Estimates (Revised)
by Zacks Equity Research
Manulife (MFC) delivered earnings and revenue surprises of 1.67% and 4.6%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Manulife Financial (MFC) Q2 Earnings Beat Estimates
by Zacks Equity Research
Manulife (MFC) delivered earnings and revenue surprises of 1.67% and 116.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Cushman & Wakefield (CWK) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cushman & Wakefield (CWK) delivered earnings and revenue surprises of 18.87% and 9.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in BRP Group (BRP): Can Its 6.1% Jump Turn into More Strength?
by Zacks Equity Research
BRP Group (BRP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
GoHealth (GOCO) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
GoHealth (GOCO) delivered earnings and revenue surprises of -33.33% and 63.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Brighthouse Financial (BHF) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Brighthouse Financial (BHF) delivered earnings and revenue surprises of 15.30% and 0.73%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Americold Realty Trust (COLD) Q1 FFO and Revenues Top Estimates
by Zacks Equity Research
Americold Realty Trust (COLD) delivered FFO and revenue surprises of 8.33% and 2.01%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?